Publications by authors named "George Daikos"

Claim this Profile
V
Virulence factors are preserved within carbapenem-resistant clades.
Mor N Lurie-Weinberger, Adi Cohen, Hadas Kon, Ophir Kastel, Alona Keren-Paz, George L Daikos

Virulence· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the Optimal Treatment of Metallo-Beta-Lactamase-Producing Enterobacterales Infections Using Aztreonam and Avibactam.
Yehuda Carmeli, José Miguel Cisneros, Mical Paul, Joseph W Chow, George L Daikos

Clin Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial.
Amir Nutman, Elizabeth Temkin, Jonathan Lellouche, Maayan Amar Ben Dalak, Ella Kaplan, George Daikos

Antimicrob Resist Infect Control· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aztreonam-avibactam for the treatment of serious infections caused by metallo-β-lactamase-producing Gram-negative pathogens: a Phase 3 randomized trial (ASSEMBLE).
George L Daikos, José Miguel Cisneros, Yehuda Carmeli, Minggui Wang, Chee Loon Leong

JAC Antimicrob Resist· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world study of Ceftazidime-Avibactam for the treatment of disease caused by bacteria: a plain language summary.
Alex Soriano, Philippe Montravers, Matteo Bassetti, Galina Klyasova, George Daikos

Future Microbiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens.
Mariya Huralska, Jason M Pogue, Michael Rybak, Jacinda C Abdul-Mutakabbir, Kyle Stamper, George Daikos

Clin Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Outbreak and Its Effective Control in a General Hospital.
Flora V Kontopidou, Maria Antonopoulou, Anastasia Votsi, Vassiliki Papoutsaki, Vassiliki Bereri, George L Daikos

Antibiotics (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking Through Resistance: A Comparative Review of New Beta-Lactamase Inhibitors (Avibactam, Vaborbactam, Relebactam) Against Multidrug-Resistant Superbugs.
Ilias Karaiskos, Irene Galani, George L Daikos, Helen Giamarellou

Antibiotics (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double carbapenemases in blood isolates: dissemination in a single medical center via multiple plasmids and a variety of highly efficient clones.
Anastasia Rigatou, Ayorinde O Afolayan, Elizabeth-Barbara Tatsi, Ioannis Deliolanis, Athanasios Michos, George L Daikos

Antimicrob Agents Chemother· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial.
Yehuda Carmeli, José Miguel Cisneros, Mical Paul, George L Daikos, Minggui Wang

Lancet Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations?
Beatrice Grabein, Francis F Arhin, George L Daikos, Luke S P Moore, V Balaji

Infect Dis Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of De-Escalation of Empirical Antimicrobial Therapy in Medical Wards with Recognized Prevalence of Multi-Drug-Resistant Pathogens: A Multicenter Prospective Cohort Study in Non-ICU Patients with Microbiologically Documented Infection.
Vasiliki Rapti, Garyfallia Poulakou, Anastasia Mousouli, Athanasios Kakasis, Stamata Pagoni, George L Daikos

Antibiotics (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of individual preclinical and clinical anti-infective PKPD data to predict clinical study outcomes.
Vincent Aranzana-Climent, Wisse van Os, Amir Nutman, Jonathan Lellouche, Yael Dishon-Benattar, George L Daikos

Clin Transl Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visceral Leishmaniasis in a Twin Pregnancy: A Case Report and Review of the Literature.
Grigorios Karampas, Sevasti Koulouraki, George L Daikos, Christina Nanou, Leon Aravantinos

J Clin Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA).
María Paniagua-García, Jose M Bravo-Ferrer, Salvador Pérez-Galera, Tomislav Kostyanev, Marlieke E A de Kraker, George L Daikos

Clin Microbiol Infect· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three lineages causing bloodstream infections variably dominated within a Greek hospital over a 15 year period.
Ayorinde O Afolayan, Anastasia Rigatou, Hajo Grundmann, Angeliki Pantazatou, George Daikos

Microb Genom· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in Greece.
Myrto Barmpouni, Jason P Gordon, Ryan L Miller, James W Dennis, Vassilis Grammelis, George L Daikos

Infect Dis Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii.
Hadas Kon, Amichay Hameir, Amir Nutman, Elizabeth Temkin, Alona Keren Paz, George L Daikos

Microbiol Spectr· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV RNA/DNA Levels at Diagnosis Can Predict Immune Reconstitution: A Longitudinal Analysis.
Dimitrios Basoulis, Nikos Pantazis, Dimitrios Paraskevis, Panos Iliopoulos, Martha Papadopoulou, George L Daikos

Microorganisms· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use and Effectiveness of Ceftazidime-Avibactam in Real-World Clinical Practice: EZTEAM Study.
Alex Soriano, Philippe Montravers, Matteo Bassetti, Galina Klyasova, George Daikos

Infect Dis Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA).
Salvador Pérez-Galera, Jose M Bravo-Ferrer, María Paniagua, Tomislav Kostyanev, Marlieke E A de Kraker, George L Daikos

EClinicalMedicine· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatment Options.
Myrto Barmpouni, Jason P Gordon, Ryan L Miller, Clive R J Pritchard, James W Dennis, George L Daikos

Infect Dis Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ex Vivo Evaluation of Glutamine Treatment in Sepsis and Trauma in a Human Peripheral Blood Mononuclear Cells Model.
Efrossini Briassouli, Marianna Tzanoudaki, Dimitris Goukos, Kostas Vardas, Panagiotis Briassoulis, George L Daikos

Nutrients· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms.
Keith S Kaye, Dror Marchaim, Visanu Thamlikitkul, Yehuda Carmeli, Cheng-Hsun Chiu, George Daikos

NEJM Evid· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive score for patients with carbapenemase-producing enterobacterales colonization upon admission in a tertiary care hospital in an endemic area.
Chrysanthe Papafotiou, Sotirios Roussos, Vana Sypsa, Sofia Bampali, Kalliopi Spyridopoulou, George L Daikos

J Antimicrob Chemother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis